Full-year 2020 revenue for SI-Bone, a sacropelvic device company, increased 9 percent to between $73.1 million and $73.4 million year over year, according to a preliminary unaudited report on Jan. 7.
Five things to know:
1. Fourth-quarter revenue is expected to be within the range of $21.9 million and $22.2 million, representing 11 percent to 12 percent growth compared to the same period last year.
2. Full-year U.S. revenue is projected to be between $67.9 million and $68.1 million, equating to year-over-year growth of about 10 percent. International revenue is expected to be in the range of $5.2 million to $5.3 million.
3. Cash and marketable securities are expected to be about $196 million as of Dec. 31, 2020.
4. SI-Bone will provide final financial results for the fourth quarter and full year during an earnings call in March.
5. The company announced that Jeff Dunn will step down as CEO after 14 years at the helm. Laura Francis, SI-Bone's CFO and COO, will transition into the role.